SCHEMBL10104394

SCHEMBL10104394

Cc1cc(N2CCN(C(C)C)CC2)c(F)c(C(F)(F)F)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.36
HTR2A P28223 2/20 0.34
HTR2C P28335 2/20 0.34
HTR2B P41595 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
PKM P14618 1/20 0.34
PHGDH O43175 4/20 0.33
SOS1 Q07889 1/20 0.32
GAA P10253 2/20 0.31
HRH3 Q9Y5N1 1/20 0.31
LMNA P02545 1/20 0.31
TTR P02766 1/20 0.31
ADRB2 P07550 1/20 0.31
HTR6 P50406 1/20 0.31
WDR5 P61964 1/20 0.31
TRPV4 Q9HBA0 1/20 0.31
TP53 P04637 1/20 0.31
RBP4 P02753 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10104395 0.86 HTR2A (0.32) HTR2AHTR2CHTR2BMAPTPHGDH
SCHEMBL10104326 0.83 ADRB2 (0.44) HTR2AHTR2CHTR2BKDM4EALDH1A1
SCHEMBL10104392 0.83 HTR2A (0.38) HTR2AHTR2CHTR2BALDH1A1MAPT
SCHEMBL10104401 0.81 HTR2A (0.37) HTR2AHTR2CHTR2BALDH1A1GAA
SCHEMBL10104400 0.80 PHGDH (0.34) HTR2AHTR2CHTR2BALDH1A1MAPT
SCHEMBL10104333 0.79 ALDH1A1 (0.42) HSD11B1ALDH1A1MAPTSOS1GAA
SCHEMBL10104405 0.79 LMNA (0.43) KDM4EALDH1A1MAPTLMNA
SCHEMBL10104332 0.78 ADRB2 (0.40) HTR2AHTR2CHTR2BKDM4EALDH1A1
SCHEMBL10104391 0.78 ALDH1A1 (0.39) HTR2AHTR2CHTR2BALDH1A1GAA
SCHEMBL10104407 0.77 DRD4 (0.36) HTR2AHTR2CHTR2BALDH1A1ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8889665-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-11-18 US disclosed
US-8778929-B2 Substituted heteroaryl inhibitors of B-RAF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-07-15 US disclosed
US-8653087-B2 Pyrido [5, 4-D] pyrimidines as cell proliferation inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-02-18 US disclosed
US-20120094975-A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-19 US disclosed
US-20110312939-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 US disclosed
US-20110183952-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183952-A1 NEW CHEMICAL COMPOUNDS MKI67, CCNA1, CCNT1 HSD11B1 221/4885HTR2A 3601/4885HTR2C 2640/4885
US-20110312939-A1 NEW CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 HSD11B1 283/4885HTR2A 4089/4885HTR2C 2673/4885
US-20120094975-A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS CCNT1, CCNA1, CCND1 HSD11B1 3682/4885HTR2A 2935/4885HTR2C 2276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.